ScinoPharm Taiwan Ltd (1789) — Working Capital to Net Assets Ratio
ScinoPharm Taiwan Ltd (1789) has a Working Capital to Net Assets ratio of 47.0% as of March 2026. Working capital of NT$4.85 Billion (current assets of NT$5.73 Billion minus current liabilities of NT$873.54 Million) is measured against net assets of NT$10.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of ScinoPharm Taiwan Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ScinoPharm Taiwan Ltd Working Capital to Net Assets (2007–2025)
This chart shows how ScinoPharm Taiwan Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 47.0%, reflecting working capital of NT$4.85 Billion against net assets of NT$10.31 Billion TWD. See ScinoPharm Taiwan Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for ScinoPharm Taiwan Ltd (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ScinoPharm Taiwan Ltd from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of ScinoPharm Taiwan Ltd.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.4% | NT$4.78 Billion | NT$10.52 Billion | NT$5.49 Billion | NT$709.84 Million | ▼ -10.1 pp |
| 2024 | 55.5% | NT$5.84 Billion | NT$10.53 Billion | NT$6.61 Billion | NT$767.68 Million | ▲ +1.0 pp |
| 2023 | 54.5% | NT$5.65 Billion | NT$10.36 Billion | NT$6.38 Billion | NT$729.45 Million | ▲ +1.7 pp |
| 2022 | 52.8% | NT$5.52 Billion | NT$10.45 Billion | NT$6.32 Billion | NT$803.09 Million | ▲ +1.3 pp |
| 2021 | 51.5% | NT$5.41 Billion | NT$10.51 Billion | NT$5.97 Billion | NT$556.31 Million | ▲ +1.8 pp |
| 2020 | 49.7% | NT$5.23 Billion | NT$10.53 Billion | NT$5.92 Billion | NT$686.65 Million | ▲ +4.2 pp |
| 2019 | 45.5% | NT$4.66 Billion | NT$10.26 Billion | NT$5.41 Billion | NT$741.75 Million | ▲ +2.2 pp |
| 2018 | 43.3% | NT$4.56 Billion | NT$10.54 Billion | NT$6.51 Billion | NT$1.95 Billion | ▼ -8.1 pp |
| 2017 | 51.4% | NT$5.35 Billion | NT$10.42 Billion | NT$6.47 Billion | NT$1.12 Billion | ▲ +3.5 pp |
| 2016 | 47.8% | NT$4.89 Billion | NT$10.23 Billion | NT$6.59 Billion | NT$1.69 Billion | ▲ +9.7 pp |
| 2015 | 38.1% | NT$3.76 Billion | NT$9.86 Billion | NT$6.03 Billion | NT$2.27 Billion | ▲ +2.6 pp |
| 2014 | 35.5% | NT$3.33 Billion | NT$9.38 Billion | NT$5.25 Billion | NT$1.92 Billion | ▼ -9.8 pp |
| 2013 | 45.3% | NT$4.37 Billion | NT$9.64 Billion | NT$6.14 Billion | NT$1.77 Billion | ▼ -8.2 pp |
| 2012 | 53.5% | NT$4.85 Billion | NT$9.07 Billion | NT$6.06 Billion | NT$1.20 Billion | ▼ -5.0 pp |
| 2011 | 58.5% | NT$5.01 Billion | NT$8.56 Billion | NT$5.87 Billion | NT$857.79 Million | ▲ +6.4 pp |
| 2010 | 52.2% | NT$3.48 Billion | NT$6.68 Billion | NT$4.08 Billion | NT$595.31 Million | ▲ +5.5 pp |
| 2009 | 46.7% | NT$2.09 Billion | NT$4.47 Billion | NT$2.77 Billion | NT$682.53 Million | ▼ -15.7 pp |
| 2008 | 62.4% | NT$2.15 Billion | NT$3.44 Billion | NT$2.60 Billion | NT$455.55 Million | ▼ -8.8 pp |
| 2007 | 71.3% | NT$1.81 Billion | NT$2.53 Billion | NT$2.14 Billion | NT$333.25 Million | — |